Trial intelligence / Profile preview

Avanafil in Erectile Dysfunction (CEDAR)

NCT02503306Phase 3Completed

Sponsor
Sanofi
Start
Jul 2015
Primary completion
Mar 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of avanafil in erectile dysfunction (ED), sponsored by Sanofi. Started Jul 2015; status: completed.

02

Drugs

avanafil
03

Conditions

erectile dysfunction (ED)

Beyond the preview

Go deeper on NCT02503306.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02503306.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call